Healthcare -
Biotechnology - NASDAQ - US
$ 35.06
-9.8 %
$ 3.29 B
Market Cap
-5.57
P/E
RARE - TOTAL EQUITY
Total Equity RARE - Ultragenyx Pharmaceutical Inc.
262 M
LAST VALUE
-13.74%
2 YEAR CAGR
-16.69%
5 YEAR CAGR
3.56%
10 YEAR CAGR